SrilathaEdupugantiMD
[Pronunciation: Sri]
Infectious Disease • Atlanta, GAProfessor, Medicine, Emory University School of Medicine
Dr. Edupuganti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
80 Jesse Hill Jr Dr SE
Atlanta, GA 30303Phone+1 404-778-7717
Education & Training
University of North CarolinaMPH, Epidemiology, 2005
Emory University School of MedicineFellowship, Infectious Disease, 1995 - 1997
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1992 - 1995
Louisiana State University School of Medicine in New OrleansClass of 1992
Certifications & Licensure
GA State Medical License 1995 - 2025
NC State Medical License 1997 - 2018
LA State Medical License 1994 - 1995
Awards, Honors, & Recognition
- HVTN Citizenship Award HIV vaccine trials network, 2019
- Paper of the year International Society of Vaccines, 2017
- Member of Alpha Omega Alpha Honor Medical Society 1992
Clinical Trials
- Human Immune Responses to Yellow Fever Vaccination Start of enrollment: 2008 May 01
- Measles, Mumps, and Rubella (MMR) Immunity in College Students Start of enrollment: 2010 Mar 01
- Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine Start of enrollment: 2011 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 348 citationsHomologous and Heterologous Covid-19 Booster Vaccinations.Robert L Atmar, Kirsten E Lyke, Meagan E Deming, Lisa A Jackson, Angela R Branche
The New England Journal of Medicine. 2022-03-17 - 645 citationsThe receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, David R. Martinez, Rajendra Raut
Science Immunology. 2020-06-11 - 10 citationsNeutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.Nonhlanhla N Mkhize, Anna E J Yssel, Haajira Kaldine, Rebecca T van Dorsten, Amanda S Woodward Davis
Plos Pathogens. 2023-06-01
Press Mentions
Emory University Participating in First-of-Its-Kind HIV Vaccine TrialJuly 21st, 2022- Emory Participating in Trial to Test mRNA HIV Vaccine in HumansJune 7th, 2022
- The Only Way We’ll Know When We Need COVID-19 BoostersJune 23rd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
